Efficacy of intra-articular hyaluronan (Synvisc®) for the treatment of osteoarthritis affecting the first metatarsophalangeal joint of the foot (hallux limitus): Study protocol for a randomised placebo controlled trial

Journal of Foot and Ankle Research

Volumn 2, Issue 1, 2009, Pages

  Munteanu, Shannon E ^a   Menz, Hylton B ^a   Zammit, Gerard V ^a   Landorf, Karl B ^a   Handley, Christopher J ^a   ElZarka, Ayman ^a   DeLuca, Jason ^a  

^a LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 72349086809     PISSN: None     EISSN: 17571146     Source Type: Journal    
DOI: 10.1186/1757-1146-2-2     Document Type: Article

References (51)

1. Camasta C. Hallux limitus and hallux rigidus. Clinical examination, radiographic findings, and natural history. Clin Podiatr Med Surg 1996, 13(3):423-448. 8829034.
2. Coughlin MJ, Shurnas PS. Hallux rigidus: demographics, eitology and radiographic assessment. Foot Ankle Int 2003, 24(10):731-743.
3. van Saase JL, van Romunde LK, Cats A, Vandenbroucke JP, Valkenburg HA. Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis 1989, 48(4):271-280. 1003741, 2712610, 10.1136/ard.48.4.271.
4. Gorter K, Kuyvenhoven M, de Melker R. Nontraumatic foot complaints in older people. A population-based survey of risk factors, mobility, and well-being. J Am Podiatr Med Assoc 2000, 90(8):397-402.
5. Weinfeld SB, Schon LC. Hallux metatarsophalangeal arthritis. Clin Orthop Relat Res 1998, (349):9-19. 10.1097/00003086-199804000-00003, 9584362.
6. Vanore JV, Christensen JC, Kravitz SR, Schuberth JM, Thomas JL, Weil LS, Zlotoff HJ, Couture SD. Diagnosis and treatment of First Metatarsophalangeal Joint Disorders. Section 2: Hallux rigidus. J Foot Ankle Surg 2003, 42(3):124-136. 10.1016/S1067-2516(03)70015-5, 12815579.
7. Dugowson CE, Gnanashanmugam P. Nonsteroidal anti-inflammatory drugs. Phys Med Rehabil Clin N Am 2006, 17(2):347-354.
8. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl 1993, 39:3-9.
9. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006, 19(2):CD005321. 16625635 .
10. Pendleton A, Arden N, Dougados M, Doherty M, Bannwarth B, Bijlsma JWJ, Cluzeau F, Cooper C, Dieppe PA, Gunther K-P, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2000, 59(12):936-944. 1753053, 11087696, 10.1136/ard.59.12.936.
11. None American College of Rheumatology Subcommittee on Osteoarthritis Guidelines: Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000, 43(9):1905-1915. 10.1002/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P, 11014340, None.
12. Campbell J, Bellamy N, Gee T. Differences between systematic reviews/meta-analyses of hyaluronic acid/hyaluronan/hylan in osteoarthritis of the knee. Osteoarthritis Cartilage 2007, 15(12):1424-1436. 10.1016/j.joca.2007.01.022, 17448701.
13. Pons M, Alvarez F, Solana J, Viladot R, Varela L. Sodium hyaluronate in the treatment of hallux rigidus. A single-blind, randomized study. Foot Ankle Int 2007, 28(1):38-42. 10.3113/FAI.2007.0007, 17257536.
14. Maher A. An audit of the use of sodium hyaluronate 1% (Ostenil® Mini) therapy for the treatment of hallux rigidus. Br J Podiatry 2007, 10(2):47-51.
15. Karasick D, Wapner K. Hallux rigidus deformity: radiologic assessment. Am J Roentgenol 1991, 157(5):1029-1033. 1927789 .
16. Lo GH, LaValley M, McAlindon T, Felson DT. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: A meta-analysis. JAMA 2003, 290(23):3115-3121. 10.1001/jama.290.23.3115, 14679274.
17. Godlee F. Publishing study protocols: Making them visible will improve registration, reporting and recruitment. BMC News and Views 2001, 2:4.
18. Altman R, Brandt K, Hochberg M, Moskowitz R, Bellamy N, Bloch DA, Buckwalter J, Dougados M, Ehrlich G, Lequesne M, et al. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis Cartilage 1996, 4(4):217-243. 10.1016/S1063-4584(05)80101-3, 11048620.
19. Menz HB, Munteanu SE, Landorf KB, Zammit GV, Cicuttini FM. Radiographic classification of osteoarthritis in commonly affected joints of the foot. Osteoarthritis Cartilage 2007, 15(11):1333-1338. 10.1016/j.joca.2007.05.007, 17625925.
20. Garrow AP, Papageorgiou A, Silman AJ, Thomas E, Jayson MIV, Macfarlane GJ. The Grading of hallux valgus: The Manchester Scale. J Am Podiatr Med Assoc 2001, 91(2):74-78. 11266481.
21. McLeod Roberts J. Vascular Assessment. Assessment of the Lower Limb 2002, 79-112. Edinburgh: Elsevier: Churchill Livingstone, Merriman LM, Turner W, Second.
22. Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, Gerster J, Jacobs J, Leeb B, Liote F, et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006, 65(10):1312-1324. 10.1136/ard.2006.055269, 16707532.
23. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975, 23(10):433-441.
24. Bennett P, Patterson C, Wearing S, Baglioni T. Development and validation of a questionnaire designed to measure foot-health status. J Am Podiatr Med Assoc 1998, 88(9):419-428.
25. Landorf KB, Burns J. Health outcome assessment. Merriman's Assessment of the Lower Limb 2008, Edinburgh: Elsevier: Churchill Livingstone, Yates B, 3, .
26. Martin RL, Irrgang JJ. A Survey of Self-reported Outcome Instruments for the Foot and Ankle. J Orthop Sports Phys Ther 2007, 37(2):72-84. 10.2519/jospt.2007.2403, 17366962.
27. Suk M, Hanson BP, Norvell DC, Helfet DL. AO Handbook - Musculoskeletal Outcome Measures and Instruments. 2005, Basel: Thieme.
28. McDowell I. Measuring Health: A Guide to Rating Scales and Questionnaires. 2006, Oxford: Oxford University Press, 3.
29. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986, 29(8):1039-1049. 10.1002/art.1780290816, 3741515.
30. Hopson M, McPoil T, Cornwall M. Motion of the first metatarsophalangeal joint. Reliability and validity of four measurement techniques. J Am Podiatr Med Assoc 1995, 85(4):198-204.
31. Menz HB, Zammit GV, Munteanu SE, Scott G. Plantarflexion strength of the toes: age and gender differences and evaluation of a clinical screening test. Foot Ankle Int 2006, 27(12):1103-1108.
32. Bryant A, Singer K, Tinley P. Comparison of the reliability of plantar pressure measurements using the two-step and midgait methods of data collection. Foot Ankle Int 1999, 20(10):646-650.
33. van der Leeden M, Dekker JH, Siemonsma PC, Lek-Westerhof SS, Steultjens MP. Reproducibility of plantar pressure measurements in patients with chronic arthritis: a comparison of one-step, two-step, and three-step protocols and an estimate of the number of measurements required. Foot Ankle Int 2004, 25(10):739-744. 15566706.
34. Ware J, Sherbourne C. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30(6):473-483. 10.1097/00005650-199206000-00002, 1593914.
35. McHorney CA, Ware JE, Rogers W, Raczek AE, Lu JF. The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. Med Care 1992, 30(5 Suppl):MS253-265. 10.1097/00005650-199205001-00025, 1583937.
36. McHorney CA, Ware JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993, 31(3):247-263. 10.1097/00005650-199303000-00006, 8450681.
37. McHorney CA, Ware JE, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994, 32(1):40-66. 10.1097/00005650-199401000-00004, 8277801.
38. Sun SF, Chou YJ, Hsu CW, Hwang CW, Hsu PT, Wang JL, Hsu YW, Chou MC. Efficacy of intra-articular hyaluronic acid in patients with osteoarthritis of the ankle: a prospective study. Osteoarthritis Cartilage 2006, 14(9):867-874. 10.1016/j.joca.2006.03.003, 16635582.
39. Lee PB, Kim YC, Lim YJ, Lee CJ, Sim WS, Ha CW, Bin SI, Lim KB, Choi SS, Lee SC. Comparison between high and low molecular weight hyaluronates in knee osteoarthritis patients: Open-label, randomized, multicentre clinical trial. J Int Med Res 2006, 34(1):77-87.
40. Keech AC, Wonders SM, Cook DI, Gebski VJ. Balancing the outcomes: reporting adverse events. Med J Aust 2004, 181(4):215-218.
41. Jüni P, Reichenbach S, Trelle S, Tschannen B, Wandel S, Jordi B, Züllig M, Guetg R, Häuselmann HJ, Schwarz H, et al. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial. Arthritis Rheum 2007, 56(11):3610-3619. 10.1002/art.23026, 17968921.
42. Friedman LM, Furberg CD, DeMets DL. Fundamentals of Clinical Trials. 1998, New York: Springer.
43. Landorf KB, Radford JA. Minimal important difference: Values for the Foot Health Status Questionnaire, Foot Function Index and Visual Analogue Scale. The Foot 2008, 18(1):15-19.
44. Gilheany MF, Landorf KB, Robinson P. Hallux valgus and hallux rigidus: a comparison of impact on health-related quality of life in patients presenting to foot surgeons in Australia. J Foot Ankle Res 2008, 1(1):14. 2615430, 19077213, 10.1186/1757-1146-1-14.
45. Gibaldi M, Sullivan S. Intention-to-treat analysis in randomized trials: who gets counted?. J Clin Pharmacol 1997, 37(8):667-672.
46. Sheiner LB, Rubin DB. Intention-to-treat analysis and the goals of clinical trials. Clin Pharmacol Ther 1995, 57:6-15. 10.1016/0009-9236(95)90260-0, 7828382.
47. Newell DJ. Intention-to-treat analysis: Implications for quantitative and qualitative research. Int J Epidemiol 1992, 21(5):837-841. 10.1093/ije/21.5.837, 1468842.
48. Peat JK, Barton B. Medical Statistics: A Guide to Data Analysis and Critical Appraisal. 2005, Malden, Massachusetts: Blackwell.
49. Vickers AJ, Altman DG. Statistics Notes: Analysing controlled trials with baseline and follow up measurements. BMJ 2001, 323(7321):1123-1124. 1121605, 11701584, 10.1136/bmj.323.7321.1123.
50. Twisk J, Proper K. Evaluation of the results of a randomized controlled trial: how to define changes between baseline and follow-up. J Clin Epidemiol 2004, 57(3):223-228. 10.1016/j.jclinepi.2003.07.009, 15066681.
51. Kirwan J. Is there a place for intra-articular hyaluronate in osteoarthritis of the knee?. Knee 2001, 8(2):93-101. 10.1016/S0968-0160(01)00075-8, 11337235.